PaySign, Inc. Q4 2025 Earnings Call Summary

Maintained a market share of just under 50% in the plasma space, exiting the year with 595 active centers despite elevated inventory levels impacting per-center revenue.Plasma donor compensation business provided a stable foundation with 4% revenue growth, shifting focus toward center efficiency and excess capacity filling over new openings.Successfully expanded footprint within the top 10 U.S. pharmaceutical manufacturers, now serving 6 of the top 10 through a land-and-expand strategy.Differentiated 'dynam ...